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Transport of the precursor for carbamoyl-phosphate synthetase I into mitochondria n Reuber hepatoma 
H-35 cells was inhibited by adding monensin or nigericin to the culture medium at a concentration of
0.5 PM, and the enzyme precursor accumulated, mainly in the cytosolic fraction. Accumulated precursor 
was degraded slowly with a half-life of more than 16 min. Valinomycin, nonactin, A23187, X-537A 
(lasalocid), bromo-lasalocid, and carbonyl cyanide m-chlorophenylhydrazone did not exhibit these effects 
at concentrations at which they did not inhibit protein synthesis of the cells. 
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1. INTRODUCTION 
Carbamoyl-phosphate synthetase I (CPS-I) is 
one of the limited number of mammalian proteins 
for which transport into mitochondria is well 
documented. This enzyme is synthesized on 
cycloheximide-sensitive ribosomes [l] as a precur- 
sor (pCPS-I) with a larger M, than the mature en- 
zyme, and is then processed into the mature size 
either coincident with or immediately after 
transport into the mitochondrial matrix [2,3]. 
Authors in [4] reported that the processing of 
pCPS-I in liver explants was inhibited by a pro- 
tease inhibitor, p-aminobenzamidine. In their ex- 
periment, newly synthesized pCPS-I was almost in- 
Abbreviations: CPS-I, carbamoyl-phosphate synthetase 
I; pCPS-I, precursor for CPS-I; CCCP, carbonyl 
cyanide m-chlorophenylhydrazone; Hepes, 4-(2-hy- 
droxyethyl)l-piperazineethanesulfonic acid; SDS, 
sodium dodecyl sulfate; PMSF, phenylmethylsulfonyl 
fluoride 
Mitochondrial enzyme 
stantly degraded rather than accumulated in the 
cells [4]. Authors in [5] found that a fluorescent 
dye, rhodamine 123, inhibited the intake of pCPS- 
I into mitochondria of isolated hepatocytes. They 
observed accumulation of pCPS-I in the cells and 
found that this pCPS-I was slowly degraded with 
an apparent tl/, of 10 min [5]. 
Schatz and his associates found that the ac- 
cumulation of precursor for several mitochondrial 
proteins of yeast was caused by an uncoupler of 
oxidative phosphorylation, CCCP [6,7], and 
developed conditions under which large amounts 
of precursors accumulate in yeast [8]. With animal 
cells, however, inhibition of intake of precursors 
into mitochondria by uncouplers or ionophores 
has not been reported. Monovalent carboxylic 
ionophores are known to interfere with the in- 
tracellular transport of secretory [9, lo], plasma 
membrane [l I], and lysosomal proteins [12] with 
protein synthesis of the cells preserved. We 
describe here inhibition of the transport of pCPS-I 
into mitochondria of Reuber hepatoma H-35 cells 
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by monensin and nigericin. Accumulation of 
pCPS-I was observed mainly in the cytosolic frac- 
tion, and this pCPS-I was slowly degraded with an 
apparent tl/, > 16 min. 
2. MATERIALS AND METHODS 
Monensin, valinomycin, and nonactin were ob- 
tained from Calbiochem. Nigericin, CCCP, and 
X-537A (lasalocid) were from Sigma. Bromo- 
lasalocid was a gift from Dr E. Racker (Cornell 
University). All other materials and chemicals were 
obtained as in [13]. 
The stock culture of Reuber hepatoma H-35 was 
grown in 60-mm culture dishes from NUNC (Den- 
mark) as in [13]. For the preparation of cells for 
labeling with [3sS]methionine (Amersham), 0.2 ml 
of a cell suspension (5 x lo4 cells/ml) was put into 
each U-shaped well of a 96-well microtest plate 
from NUNC and incubated at 37°C under a 
humidified atmosphere of 5% CO2 and 95% air. 
After 4-5 days, when the monolayer of cells was 
confluent, the medium was changed to 50 pl of the 
preincubation medium containing methionine-free 
Eagle’s minimal essential medium, 20 mM Hepes 
at pH 7.4 (instead of sodium bicarbonate) and the 
indicated concentration of ionophore, and in- 
cubated for 30 min at 37°C under air. Labeling of 
cells was initiated by changing the medium to 20 ~1 
of a labeling medium in which [3sS]methionine was 
added to the preincubation medium at a concentra- 
tion of 0.637 mCi/ml. After labeling at 37°C 
under air for the indicated period, the cells were 
lysed by adding 20,ul of a buffer containing 
20 mM Tris-HCl, 4 mM EDTA, 2% Triton 
X-100, 0.2% SDS, and 2 mM PMSF (pH 7.4). In- 
soluble material was spun out from the cell lysate 
with a Beckman Microfuge B and the supernatant 
was frozen at - 20°C before immunoprecipitation. 
For the chase of labeled cells, 60 ~1 of the chasing 
medium, containing 27 mM unlabeled methionine 
and 133 pg/ml of cycloheximide in addition to 
preincubation medium, was added at the end of 
the labeling period. After chasing the cells for the 
indicated period, the cells were lysed as described 
above. 
Cells for the study of intracellular location of 
pCPS-I were harvested from the 60 mm culture 
dishes by scraping, and suspended in the prein- 
cubation medium without ionophores. After pack- 
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ing the cells by gentle centrifugation, cells cor- 
responding to 2.5 x 10’ were suspended in 50~1 
preincubation medium with or without 1.67 PM 
monensin. After preincubation for 30 min at 37°C 
under air, 50~1 of a labeling medium containing 
1.27 mCi/ml of [35S]methionine in addition to 
preincubation medium was added. The cells were 
labeled for 15 min and were fractionated into 
cytosolic and particulate fractions as in [ 131. 
Immunoprecipitation of pCPS-I and CPS-I 
from labeled cell lysates, SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE), and fluorography 
of dried gels were carried out as in [ 131. 
3. RESULTS AND DISCUSSION 
After preincubation with various concentrations 
of monensin or nigericin, Reuber hepatoma H-35 
cells were incubated with [35S]methionine in the 
presence of the same concentration of ionophore. 
Fig.lA depicts the effect of ionophores on 
[3SS]methionine incorporation into cell proteins. 
Slight inhibition was observed with monensin at 
0.5 PM but about 50% of the activity was still pre- 
sent even with 5 PM monensin. The effect of 
nigericin was stronger than that of monensin, with 
almost complete inhibition of incorporation 
observed at 5 PM. The [35S]methionine-labeled cell 
lysate was immunoprecipitated with anti-CPS-I 
and the immunoprecipitate analyzed with 
SDS-PAGE and fluorography (fig.lB). In the 
presence of 20.5 PM monensin, the processing of 
pCPS-I to CPS-I was inhibited. Although this ef- 
fect of monensin could be an indirect effect 
through action on protein synthesis (fig.lA), this 
result more likely indicates that processing of 
pCPS-I in vivo requires energy, as interpreted 
from the effect of CCCP on the precursors for 
yeast Fi-ATPase [6]. In the case of nigericin, in- 
hibition of the processing was observed at 0.5 PM 
(fig. lB), but at higher concentrations, radioactivi- 
ty in pCPS-I could not be detected because of the 
inhibition of protein synthesis. The effects of other 
ionophores or uncouplers such as valinomycin 
(0.03 PM), nonactin (0.5 PM), A23187 (10 PM), 
X-537A (5 PM), bromo-lasalocid (5 PM), and 
CCCP (1 PM) were also studied. These reagents 
almost completely inhibited [35S]methionine incor- 
poration of cells at the above concentrations. At 
lower concentrations, these ionophores or un- 
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coupler did not noticeably inhibit the processing of 
pCPS-I (not shown). 
To determine the intracellular location of ac- 
cumulated pCPS-I, Reuber hepatoma H-35 cells 
were incubated with [35S]methionine in the 
pCPS4, 
CPSI’ 
Q MONENSIN 
n NIGERICIN 
1 
Concentration of lonophore (uM) 
MONENSIN NIGERICIN 
Fig. 1. Effect of monensin and nigericin on the synthesis 
of the precursor (pCPS-I) and the mature form (CPS-I) 
of carbamoyl-phosphate synthetase I in Reuber 
hepatoma H-35 cells. Reuber hepatoma H-35 cells (5 x 
104) in a U-shaped well of a 96-well microtest plate were 
preincubated with methionine-free, Hepes buffered 
Eagle’s minimum essential medium containing the 
indicated concentrations of monensin or nigericin. After 
preincubation, cells were labeled with [“Slmethionine 
(0.637 mCi/ml) for 30 min at 37°C and the cells were 
lysed with a solution containing detergents. (A) 
Trichloroacetic acid insoluble radioactivity of cells was 
measured. (B) Cell lysate corresponding to 1.25 x lo4 
cells was immunoprecipitated and analyzed by 
SDS-PAGE and fluorography as described in section 2. 
The numbers at the top of the lanes indicate the 
concentration of ionophores in pM. A separation gel of 
Fig.2. Subcellular location of the precursor (pCPS-I) 
and the mature form (CPS-I) of carbamoyl-phosphate 
synthetase I in the presence or absence of monensin. 
Suspensions of Reuber hepatoma H-35 cells (2.5 x lo5 
cells/50 ~1) were preincubated in the presence or absence 
of 1.67 PM of monensin as in fig. 1 and labeled for 
15 min by adding 50~1 preincubation medium 
containing 1.27 mCi/ml of [3SS]methionine. The labeled 
cells were fractionated into cytosolic (S) and particulate 
(P) fractions with digitonin, as described in section 2. 
Both fractions corresponding to 6.25 x 104 cells were 
immunoprecipitated and analyzed by electrophoresis 
and fluorography. A separation gel of 4% acrylamide 
was used for electrophoresis, and the lower part of the 
Wo acrylamide was used for the electrophoresis. fluorogram is shown. 
presence or absence of 1.67 pM monensin and 
fractionated into cytosolic and particulate frac- 
tions. As shown in fig.2, accumulation of pCPS-I 
was observed mainly in the cytosolic fraction. The 
precursor found in the particulate fraction in the 
presence of monensin may be due to either con- 
tamination from the cytosolic fraction or interac- 
tion of the precursor with a receptor site on the 
mitochondrial surface [ 141. 
Stability of pCPS-I in Reuber hepatoma H-35 
cells was studied by pulse-chase labeling in the 
presence or absence of monensin (fig.3). In the 
absence of monensin, labeled pCPS-I disappeared 
within 4 min as the result of processing into CPS-I. 
MONENSIN 
+ -- 
SPSP 
pCPS+a 
CPS*I-’ 
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Fig.3. Chasing the labeled cells in the presence or 
absence of monensin. A monolayer of Reuber hepatoma 
H-35 cells in a 96-well microtest plate with U-shaped 
wells was labeled for 15 min after preincubation as in 
fig. 1. At the end of the labeling period, 60 ~1 medium 
containing 27 mM unlabeled methionine and 133 ,ug/ml 
of cycloheximide with and without 1.67 pM monensin 
was added. The numbers at the top of lanes indicate the 
time of chasing in min. After the indicated chasing 
period, the cells were lysed and the radioactivity in the 
precursor (pCPS-I) and the mature form (CPS-I) of 
carbamoyl-phosphate synthetase I was analyzed as in 
fig. 1. A separation gel of 5% acrylamide was used for 
the electrophoresis. 
When the processing was blocked by monensin, 
pCPS-I became very stable and only a slight 
decrease of radioactivity in pCPS-I was observed 
during the 16 min of chasing. This result is in clear 
contrast to that of authors in [4], who reported 
that pCPS-I was almost instantly degraded in liver 
explants when the processing was blocked with p- 
aminobenzamidine. It may be that damage to the 
hepatocyte in their liver explants caused this dif- 
ference. Authors in [5] estimated an apparent ts 
of 10 min for the degradation of pCPS-I in 
isolated hepatocytes when the processing was in- 
hibited by rhodamine 123. The degradation in their 
experiment seems to be faster than that in our 
experiment. 
Because our result suggested that monensin can 
be used to accumulate large amounts of pCPS-I, 
the incorporation of [35S]methionine into pCPS-I 
in the presence of monensin was examined for a 
longer period. However, the accumulation of 
radioactive pCPS-I was limited because the course 
of the incorporation into pCPS-I declined within 
15 min, when incorporation into CPS-I in the 
absence of monensin was still linear (fig.4). This 
result cannot be due to the viability of the cells, 
because [35S]methionine incorporation into total 
cell proteins was linear even in the presence of 
monensin (not shown). The most likely explana- 
tion for this limited amount of accumulated pCPS- 
I is degradation. However, the results presented in 
fig.3 indicate that the degradation has a tl/, of 
more than 16 min. On the other hand, fig.4 sug- 
gests the decline of [35S]methionine incorporation 
into pCPS-I within 15 min. Analysis of these 
- MONENSIN +MONENSIN 
lin) 
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Fig.4. Course of the synthesis of the precursor (pCPS-I) 
and the mature form (CPS-I) of carbamoyl-phosphate 
synthetase I in the presence or absence of monensin. A 
monolayer of Reuber hepatoma H-35 cells was labeled 
for the indicated times in the presence or absence of 
1.67 ,uM monensin as in fig.1. Radioactivity in pCPS-I 
and CPS-I was detected as in fig.1. A separation gel of 
5% acrylamide was used for electrophoresis. 
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results with the type of kinetics developed in [15) 
indicates that this decline of incorporation is too 
early to explain our results by degradation of 
pCPS-I alone. Although more detailed ex- 
periments are needed, this interpretation suggests 
the operation of some additional mechanism(s) in 
the regulation of the pCPS-I level in Reuber 
hepatoma H-35 cells. 
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